Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Regular financial reviews help you stay aligned with your goals and adjust to changing circumstances. Learn their importance for effective planning.
24,086 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
As Traeger gears up for the 2026 earnings season, investors want clarity on margins, growth, and cash flow. This anal...
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
As retirees turn 65, the six-month Medigap window is the only time insurers must offer standard rates. Missing it can...
The quantum computing space just crossed a major milestone with its first traditional IPO. This guide breaks down wha...
Ripple has won preliminary approval for a MiCA-based CASP license in Luxembourg, paving the way for regulated crypto ...
June brought a sharp turn for Newmont as gold dynamics and costs collided with production headwinds. This article bre...
A landmark agreement between Apple and Broadcom signals a major shift in chip strategy and domestic manufacturing. Th...
The record between corporate profits and worker pay has widened to a postwar high, signaling a troubling drift in the...
If you have $1,000 and want a crypto with staying power, this guide explains why Ethereum often fits the bill for lon...
Is Walmart stock a a good bet right now? This guide breaks down the facts: fundamentals, valuation, and practical ste...
A 75-year-old widow with $1.8 million in IRAs faces a higher tax bill after filing as a single taxpayer for the first...